You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
Attention over time
Attention Score history
Activity
Mendeley demographics
Login to view Mendeley reader trends over time.
| Title |
492 Phase 2 efficacy and safety of autologous tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab in immune checkpoint inhibitor-naïve patients with advanced cancers
|
|---|---|
| Published by |
BMJ, November 2021
|
| DOI | 10.1136/jitc-2021-sitc2021.492 |
| Authors |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
Mendeley demographics
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 41 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 4 | 10% |
| Student > Bachelor | 3 | 7% |
| Other | 2 | 5% |
| Student > Master | 2 | 5% |
| Researcher | 2 | 5% |
| Other | 3 | 7% |
| Unknown | 25 | 61% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 17% |
| Immunology and Microbiology | 4 | 10% |
| Biochemistry, Genetics and Molecular Biology | 3 | 7% |
| Chemical Engineering | 1 | 2% |
| Agricultural and Biological Sciences | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 25 | 61% |